M Ventures (Merck)

M Ventures (Merck) M Ventures is the strategic CVC of Merck KGaA (the German Merck, not the US pharmaceutical company), founded in 2009 with a €600M+ fund allocation. The firm has made 195 investments and developed 80+ companies from creation to exit. The dual focus spans biotechnology (healthcare, life science tools) and technology (semiconductors, display). Portfolio companies include Tignis (AI for semiconductor equipment) and MemryX (edge AI processors). On the healthcare side, the firm inve